Drug Restores Hair Growth in Patients with Alopecia Areata

Seventy-five percent of patients with moderate to severe alopecia areata—an autoimmune disease that causes patchy and, less frequently, total hair loss—had significant hair regrowth after treatment with ruxolitinib, reported researchers from Columbia University Medical Center (CUMC). By the end of their treatment, average hair regrowth was 92 percent.

Read more: http://newsroom.cumc.columbia.edu/blog/2016/09/22/drug-restores-hair-growth-in-patients-with-alopecia-areata/